{{Rsnum
|rsid=11781886
|Chromosome=8
|Orientation=plus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=NKX3-1
|position=23682904
|Gene_s=NKX3-1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 9.2 | 35.4 | 55.4
| HCB | 8.9 | 51.1 | 40.0
| JPT | 9.5 | 45.2 | 45.2
| YRI | 11.5 | 49.2 | 39.3
| ASW | 0.0 | 0.0 | 0.0
| CHB | 8.9 | 51.1 | 40.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=24894197
|Title=A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}